Intraventricular hemorrhage induces deposition of proteoglycans in premature rabbits, but their in vivo degradation with chondroitinase does not restore myelination, ventricle size and neurological recovery

Exp Neurol. 2013 Sep:247:630-44. doi: 10.1016/j.expneurol.2013.02.018. Epub 2013 Mar 6.

Abstract

Intraventricular hemorrhage (IVH) results in white matter injury and hydrocephalus in premature infants. Chondroitin sulfate proteoglycans (CSPGs)-neuorcan, brevican, versican, aggrecan and phosphacan-are unregulated in the extracellular matrix after brain injury, and their degradation enhances plasticity of the brain. Therefore, we hypothesized that CSPG levels were elevated in the forebrain of premature infants with IVH and that in vivo degradation of CSPGs would enhance maturation of oligodendrocyte, augment myelination, promote neurological recovery, and minimize hydrocephalus. We found that levels of neurocan, brevican, aggrecan, phosphacan, and versican were elevated, whereas NG2 expression was reduced in premature rabbit pups and human infants with IVH compared to controls. Intracerebroventricular chondroitinase ABC (ChABC) reduced the expression of neuorcan, brevican, versican and aggrecan, but not NG2. However, ChABC treatment did not enhance maturation of oligodendrocytes, myelination, or neurological recovery in the pups with IVH. Moreover, ChABC did not reduce gliosis or ventriculomegaly. Our results demonstrate that IVH induces distinct changes in the components of CSPGs, and that reversing these changes by in vivo ChABC treatment neither promotes clinical recovery, myelination, nor reduces ventriculomegaly in preterm rabbit pups.

Keywords: Aggrecan; Brevican; Chondroitin sulfate proteoglycans; Chondroitinase ABC; Myelination; Neuorcan; Oligodendrocyte; Phosphacan; Versican.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Animals, Newborn
  • Antigens / genetics
  • Antigens / metabolism
  • Cell Proliferation / drug effects
  • Cerebral Hemorrhage* / metabolism
  • Cerebral Hemorrhage* / pathology
  • Cerebral Hemorrhage* / physiopathology
  • Chondroitin ABC Lyase / administration & dosage
  • Chondroitin Sulfate Proteoglycans / genetics
  • Chondroitin Sulfate Proteoglycans / metabolism*
  • Disease Models, Animal
  • Female
  • Fetus
  • Gene Expression Regulation, Developmental / physiology*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Male
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Myelin Sheath / metabolism
  • Nerve Tissue Proteins / metabolism
  • Oligodendroglia / metabolism
  • Pregnancy
  • Proteoglycans / genetics
  • Proteoglycans / metabolism
  • Rabbits
  • Recovery of Function / drug effects
  • Recovery of Function / physiology*
  • Time Factors

Substances

  • Antigens
  • Chondroitin Sulfate Proteoglycans
  • Nerve Tissue Proteins
  • Proteoglycans
  • chondroitin sulfate proteoglycan 4
  • Chondroitin ABC Lyase